Monica Schenone

8.2k total citations · 3 hit papers
33 papers, 3.5k citations indexed

About

Monica Schenone is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Monica Schenone has authored 33 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 8 papers in Hematology and 6 papers in Immunology. Recurrent topics in Monica Schenone's work include Protein Degradation and Inhibitors (7 papers), Multiple Myeloma Research and Treatments (4 papers) and Ubiquitin and proteasome pathways (4 papers). Monica Schenone is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Multiple Myeloma Research and Treatments (4 papers) and Ubiquitin and proteasome pathways (4 papers). Monica Schenone collaborates with scholars based in United States, Germany and United Kingdom. Monica Schenone's co-authors include Paul A. Clemons, Vlado Dančík, Bridget K. Wagner, Steven A. Carr, Stuart L. Schreiber, Benjamin L. Ebert, Emily C. Hartman, Christie Ciarlo, Eamon Comer and Namrata D. Udeshi and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Monica Schenone

33 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

2013 1.3k citations Jan Krönke, Namrata D. Udeshi et al. Science profile →
Target identification and mechanism of action in chemical biology and drug discovery

2013 745 citations Monica Schenone, Vlado Dančík et al. Nature Chemical Biology profile →
Phenotypic drug discovery: recent successes, lessons learned and new directions

2022 165 citations Fabien Vincent, Arsenio Nueda et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Monica Schenone United States	17	2.7k	764	604	399	345	33	3.5k
Brian D. Marsden United Kingdom	30	2.7k 1.0×	318 0.4×	642 1.1×	136 0.3×	197 0.6×	65	3.9k
Evripidis Gavathiotis United States	38	4.5k 1.7×	269 0.4×	780 1.3×	414 1.0×	596 1.7×	75	5.8k
Joachim Gullbo Sweden	36	2.9k 1.1×	431 0.6×	1.1k 1.8×	500 1.3×	526 1.5×	100	4.0k
Lei Jin United States	33	2.7k 1.0×	528 0.7×	355 0.6×	422 1.1×	249 0.7×	53	4.2k
Christin Tse United States	22	3.5k 1.3×	375 0.5×	882 1.5×	252 0.6×	415 1.2×	24	4.3k
Mariam Aghajan United States	21	1.7k 0.6×	261 0.3×	260 0.4×	317 0.8×	223 0.6×	41	2.9k
Celia R. Berkers Netherlands	31	3.9k 1.5×	688 0.9×	1.4k 2.4×	1.2k 3.0×	714 2.1×	76	5.3k
Sara J. Buhrlage United States	26	1.9k 0.7×	254 0.3×	717 1.2×	200 0.5×	429 1.2×	66	2.9k
Haiying Chen United States	31	2.7k 1.0×	322 0.4×	1.0k 1.7×	764 1.9×	476 1.4×	129	4.8k
Michelle M. Lilly United States	38	2.4k 0.9×	653 0.9×	1.3k 2.2×	573 1.4×	600 1.7×	103	4.4k

Countries citing papers authored by Monica Schenone

Since Specialization

Citations

This map shows the geographic impact of Monica Schenone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Schenone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Schenone more than expected).

Fields of papers citing papers by Monica Schenone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Schenone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Schenone. The network helps show where Monica Schenone may publish in the future.

Co-authorship network of co-authors of Monica Schenone

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Schenone. A scholar is included among the top collaborators of Monica Schenone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Schenone. Monica Schenone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Qiuyu, Yu-Han H. Hsu, Bryan T. MacDonald, et al.. (2024). Protein interaction networks in the vasculature prioritize genes and pathways underlying coronary artery disease. Communications Biology. 7(1). 87–87. 4 indexed citations

Gabel, Alexander, Sebastian Zielinski, Sabina Ganskih, et al.. (2024). SHIFTR enables the unbiased identification of proteins bound to specific RNA regions in live cells. Nucleic Acids Research. 52(5). e26–e26. 4 indexed citations

Xu, Jinjin, Lingjia Kong, Bihua Li, et al.. (2023). Constitutively active autophagy in macrophages dampens inflammation through metabolic and post-transcriptional regulation of cytokine production. Cell Reports. 42(7). 112708–112708. 16 indexed citations

Vincent, Fabien, Arsenio Nueda, Jonathan Lee, et al.. (2022). Phenotypic drug discovery: recent successes, lessons learned and new directions. Nature Reviews Drug Discovery. 21(12). 899–914. 165 indexed citations breakdown →

Vincent, Fabien, et al.. (2022). Publisher Correction: Phenotypic drug discovery: recent successes, lessons learned and new directions. Nature Reviews Drug Discovery. 21(7). 541–541. 6 indexed citations

Tanenbaum, Benjamin, et al.. (2021). Identification of a Novel Regulator of Clostridioides difficile Cortex Formation. mSphere. 6(3). e0021121–e0021121. 6 indexed citations

Belizaire, Roger, Sebastian Koochaki, Namrata D. Udeshi, et al.. (2021). CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1. Blood. 137(16). 2209–2220. 29 indexed citations

Groß, Matthias, Si’Ana A. Coggins, Nitin Patil, et al.. (2020). The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer. Nature Communications. 11(1). 3214–3214. 93 indexed citations

Mohanan, Vishnu, Toru Nakata, A. Nicole Desch, et al.. (2018). C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. Science. 359(6380). 1161–1166. 78 indexed citations

10.

Mortison, Jonathan D., Monica Schenone, Ziyang Zhang, et al.. (2018). Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures. Cell chemical biology. 25(12). 1506–1518.e13. 39 indexed citations

11.

Jin, Youngnam N., Peter J. Schlueter, Nathalie Jurisch‐Yaksi, et al.. (2018). Noncanonical translation via deadenylated 3′ UTRs maintains primordial germ cells. Nature Chemical Biology. 14(9). 844–852. 7 indexed citations

12.

Munschauer, Mathias, Celina T. Nguyen, Christina R. Hartigan, et al.. (2018). The NORAD lncRNA assembles a topoisomerase complex critical for genome stability. Nature. 561(7721). 132–136. 277 indexed citations

13.

Choudhury, Atish D., Anna C. Schinzel, Maura B. Cotter, et al.. (2016). Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6. Cancer Research. 77(3). 753–765. 30 indexed citations

14.

Schneider, Rebekka K., Monica Schenone, Mónica Ventura Ferreira, et al.. (2016). Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9. Nature Medicine. 22(3). 288–297. 169 indexed citations

15.

Krönke, Jan, Namrata D. Udeshi, Anupama Narla, et al.. (2013). Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells. Science. 343(6168). 301–305. 1288 indexed citations breakdown →

16.

Schenone, Monica, Vlado Dančík, Bridget K. Wagner, & Paul A. Clemons. (2013). Target identification and mechanism of action in chemical biology and drug discovery. Nature Chemical Biology. 9(4). 232–240. 745 indexed citations breakdown →

17.

Ong, Shao‐En, Xiaoyu Li, Monica Schenone, Stuart L. Schreiber, & Steven A. Carr. (2011). Identifying Cellular Targets of Small-Molecule Probes and Drugs with Biochemical Enrichment and SILAC. Methods in molecular biology. 803. 129–140. 24 indexed citations

18.

Ong, Shao‐En, Monica Schenone, Adam A. Margolin, et al.. (2009). Identifying the proteins to which small-molecule probes and drugs bind in cells. Proceedings of the National Academy of Sciences. 106(12). 4617–4622. 237 indexed citations

19.

Margolin, Adam A., Shao‐En Ong, Monica Schenone, et al.. (2009). Empirical Bayes Analysis of Quantitative Proteomics Experiments. PLoS ONE. 4(10). e7454–e7454. 43 indexed citations

20.

Schenone, Monica, Barbara C. Furie, & Bruce Furie. (2004). The blood coagulation cascade. Current Opinion in Hematology. 11(4). 272–277. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact